Evidence map›Paper›PMID 42352497›Full record

ArticleCancers2026

Is There an Added Value of Dual-Time-Point [

Akram Al-Ibraheem, Serin Moghrabi, Baraa Alsyouf, Marwah Abdulrahman, Mahd Al-Foqaha, Farah Al-Tameemi, Bara'ah Bashabsheh, Saad Ruzzeh, Dimah Khalid Jiad, Ahmed Firas Al-Hammouri and 3 more

Abstract read
In one paragraph

Article in Cancers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Akram Al-IbraheemDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman 11942, Jordan.ORCID 0000-0002-0978-4716
Serin MoghrabiDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman 11942, Jordan.ORCID 0000-0001-9065-3715
Baraa AlsyoufDivision of Nuclear Medicine, Department of Radiology and Nuclear Medicine, University of Jordan, Amman 11942, Jordan.
Marwah AbdulrahmanDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman 11942, Jordan.ORCID 0000-0001-9863-9053
Mahd Al-FoqahaDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman 11942, Jordan.
Farah Al-TameemiDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman 11942, Jordan.
Bara'ah BashabshehDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman 11942, Jordan.
Saad RuzzehDepartment of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman 11942, Jordan.
Dimah Khalid JiadDepartment of Obstetrics and Gynecology, Jordan Hospital, Amman 11152, Jordan.
Ahmed Firas Al-HammouriInternal Medicine Department, Royal Medical Services, Amman 11855, Jordan.
Hongcheng ShiDepartment of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Ahmed Saad AbdlkadirDepartment of Nuclear Medicine, Radiotherapy and Nuclear Medicine Hospital, Bab Al-Muadham, Baghdad 10047, Iraq.ORCID 0000-0002-2009-5110
Asem MansourDepartment of Radiology, King Hussein Cancer Center (KHCC), Amman 11942, Jordan.ORCID 0000-0003-3443-5873

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

[68Ga]Ga-FAPI PET/CTdual-time-point imagingMTVSUVmaxTBRmaxTLU

Identifiers

PMID42352497
PMCPMC13296389

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.